Inspire Medical (INSP) is Gaining Strength from Its Product Offering and Differentiation

1 hour ago 1

Soumya Eswaran

Mon, April 6, 2026 astatine 8:56 AM CDT 3 min read

Mairs & Power, an concern advisor, released the fourth-quarter 2025 capitalist missive for the “Mairs & Power Small Cap Fund.” A transcript of the missive tin beryllium downloaded here. In 2025, artificial quality (AI) and marketplace attraction dominated the market. Increased concern successful exertion and AI infrastructure drove rising valuations and firm spending, starring to bubble-like tendencies. However, easing inflation, a Federal Reserve complaint chopped successful Q4, and resilient firm net provided immoderate optimism. In this environment, the Fund returned 3.98% successful 2025, trailing the Russell 2000 Total Return (TR) Index’s 12.81% gain, the S&P Small Cap 600 TR’s 6.02% return, and the Morningstar U.S. Fund Small Blend’s 7.68% gain. Macro headwinds affected smaller companies successful 2025, but the 2nd fractional of the twelvemonth saw small-cap stocks summation arsenic the labour marketplace softened. Stock enactment notably impacted performance, particularly successful Health Care, Information Technology, and Materials. While assemblage allocation positively contributed. Looking up to 2026, the Fund remains optimistic astir small-cap stocks, which are expected to turn astatine oregon supra the S&P 500's rate. In addition, delight cheque the Fund’s apical 5 holdings to cognize its champion picks successful 2025.

In its fourth-quarter 2025 capitalist letter, Mairs & Power Small Cap Fund stocks specified arsenic Inspire Medical Systems, Inc. (NYSE:INSP). Inspire Medical Systems, Inc. (NYSE:INSP) is simply a aesculapian exertion institution that focuses connected the improvement and commercialization of minimally invasive solutions for patients with obstructive slumber apnea. On April 2, 2026, Inspire Medical Systems, Inc. (NYSE:INSP) closed astatine $54.98 per share. One-month instrumentality of Inspire Medical Systems, Inc. (NYSE:INSP) was -12.70%, and its shares mislaid 61.26% implicit the past 52 weeks. Inspire Medical Systems, Inc. (NYSE:INSP) has a marketplace capitalization of $1.57 billion.

Mairs & Power Small Cap Fund stated the pursuing regarding Inspire Medical Systems, Inc. (NYSE:INSP) successful its 4th fourth 2025 capitalist letter:

"Notable detractors from comparative show during the play were Inspire Medical Systems, Inc. (NYSE:INSP), CVRx, and MGP Ingredients. Inspire Medical had a hard archetypal 3 quarters of the twelvemonth owed to challenges rolling retired a caller mentation of their product, and delays mounting up reimbursement codes and billing software. The banal rebounded somewhat successful the 4th quarter, but it wasn’t capable to flooded the weakness earlier successful the year. Inspire’s merchandise offering and differentiation successful the marketplace is inactive a strength, and supportive of continued enactment successful a ample addressable market, which is wherefore we person stuck with the stock."

Read Entire Article